Summary
BlueRock Therapeutics LLC
Founded in 2016
Description
At BlueRock, our mission is to create authentic cellular medicines to reverse devastating diseases, with the vision of improving the human condition.
Strengths
- Revenue generated per employee is greater than industry average
- Since BlueRock Therapeutics LLC was founded, the company has grown faster than the industry average
- Employees are staying with the company and less likely to churn compared to the rest of the industry
Weaknesses
- BlueRock Therapeutics LLC has a very small market share in their industry
- Revenue growth is less than the industry average
- The number of employees is not growing as fast as the industry average
- Variance of revenue growth is more than the industry average
- Web traffic rankings are worse than the industry average
Annual Revenue
BlueRock Therapeutics LLC's annual revenue
$42268000
Based on Kona Equity data
-
Revenue per employee
$211340
-
Variance of revenue growth
1.2
-
Annual revenue growth since founding
$5283500
-
Revenue growth rate from first known quarter to current
-41.8%
Employee Count
200 employees
-
Employee growth rate from first known quarter to current
-41.5%
-
Current employees on Linkedin
147
-
Churned employees
37
-
Churn rate percentage
25.17%
Executives
Emile Nuwaysir
Chief Executive Officer
e**@bluerocktx.comGreg Motz
Vice President, Head of Immunology
g**@bluerocktx.comRichard Reineke
Vice President, Gmp Manufacturing
r**@bluerocktx.comJason Anglin
Interim Chief Financial Officer
j**@bluerocktx.comTyler Aldredge
Lab Operations & Real Estate Vice President, Facilities
t**@bluerocktx.comJeffrey Lockwood
Vice President, Corporate Communications
j**@bluerocktx.comChere Beasley
Chief Technology Officer
c**@bluerocktx.comSeth Ettenberg
Chief Scientific Officer
s**@bluerocktx.comJoachim Fruebis
Chief Development Officer
j**@bluerocktx.comHanspeter Waldner
Vice President and Head of Immunology
h**@bluerocktx.comRebecca Milbury
Senior VP, People & Culture
r**@bluerocktx.comShawna Organ
Assay Development Scientist II
s**@bluerocktx.comJohn Homich
Director, Strategic Sourcing
j**@bluerocktx.comMatthew Maher
Senior Principal Engineer
m**@bluerocktx.comNhi Ho
Senior Gmp Facilities Specialist
n**@bluerocktx.comHomin Jung
Finance Consultant
h**@bluerocktx.comStefan Irion
Senior VP, Research
s**@bluerocktx.comMathias Pawlak
Associate Director and Principal Scientist, Immunology, T Cell
m**@bluerocktx.comBenjamin Acosta
Lab Operations Coordinator
b**@bluerocktx.comJim Xu
Senior Scientist, In Vivo Sciences
j**@bluerocktx.comCallan Carr
Research, Immunology, Allo Associate I
c**@bluerocktx.comBeth Krewson
Senior Vice President, General Counsel
b**@bluerocktx.comAhmed Enayetallah
Senior VP, Clinical Development
a**@bluerocktx.comJuliana Hsu
Senior Scientist, CNS Cell Biology
j**@bluerocktx.comJeffrey Ellis
Director, Financial Planning & Analysis
j**@bluerocktx.comAmy Gerolamo
Senior AP Specialist ( Contract )
a**@bluerocktx.comHang Yuan
Vice President, Process Development
h**@bluerocktx.comAngela Keightley
Vice President, Assay Development
a**@bluerocktx.comPhone Therapeutics
Chief Scientific Officer
p**@bluerocktx.comAinslie Little
Senior VP, Corporate Strategy
a**@bluerocktx.comG Score - 3
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G2 Income per employee more than industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
- G8 LinkedIn Churn is lower than the industry average.
Web Analysis
-
Rank
2.91 M
-
Page views per visitor
2.0
-
Daily time
2:48
Location
Unlock unlimited leads
Similar Companies
Key Information
- Name: BlueRock Therapeutics LLC
- Category: Biotechnology
- Industry: Biotechnology Company
- SIC: 80; 283
- NAICS: 541; 5417
See similar companies
-
By City Cambridge Small Biotechnology Company in Cambridge Mid-size Biotechnology Company in Cambridge Biotechnology in Cambridge Small Biotechnology in Cambridge Mid-size Biotechnology in Cambridge
-
By State MA Small companies in MA Biotechnology in MA Small Biotechnology in MA Mid-size Biotechnology in MA Small Biotechnology Company in MA Mid-size Biotechnology Company in MA
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Biotechnology and Biotechnology Company
-
Firmographic data G Score of 3 Founded in 2016 SIC: 80 SIC: 283 NAICS: 541 NAICS: 5417 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
BlueRock Therapeutics LLC's headquarters are located at 1 Broadway Cambridge, MA 02142.
BlueRock Therapeutics LLC's official website is bluerocktx.com
BlueRock Therapeutics LLC's annual revenue is $42.3 M.
BlueRock Therapeutics LLC's SIC: 80; 283
BlueRock Therapeutics LLC's NAICS: 541; 5417.
BlueRock Therapeutics LLC has 200 employees
BlueRock Therapeutics LLC is in the industry of Biotechnology.